[Retracted] Clinical Application of Anlotinib Combined with Docetaxel: Safe and Effective Treatment for Lung Carcinoma

Table 4

Comparison of clinical data between the two groups (%).

Group	Number of patients	Survival rate	Mortality rate
Control group	42	8 (19.05)	34 (80.95)
Experimental group	42	23 (54.76)	19 (45.24)
	—	11.503
	—	0.001